The US Food & Drug Administration (FDA) posted information on the flu vaccine composition for the 2025-2026 US flu season. The agency, in consultation with federal partners, reviewed the available data and made its recommendations to manufacturers of the US-licensed influenza vaccines for the production of updated vaccines for the 2025-2026 flu season. Based on this timing, the agency does not anticipate any impact on vaccine supply or timing of availability.
